Interleukin-1 beta targeted therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Interleukin-1 beta targeted therapy, covering 2025-05-20 to 2025-05-20. Get the full timeline:
Most recent: Clinical Trial Update: The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis [Phase 3]